Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen in ALS
NCT02166944Phase 2Completed
- Sponsor
- Taipei Medical University Shuang Ho Hospital
- Start
- Apr 2014
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tamoxifen in amyotrophic lateral sclerosis (ALS), sponsored by Taipei Medical University Shuang Ho Hospital. Started Apr 2014; status: completed.
02
Drugs
tamoxifen
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT02166944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02166944.